LUCD (STOCKS)
Lucid Diagnostics Inc. Common Stock
$1.210000
+0.000000 (+0.00%)
Prev close: $1.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Lishan Aklog
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $158.63M
- Employees
- 70
- P/E (TTM)
- -1.34
- P/B (TTM)
- -5.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $4.40M |
| Benefits Costs and Expenses | $57.68M |
| Costs And Expenses | $57.68M |
| Operating Expenses | $52.40M |
| Research and Development | $5.41M |
| Other Operating Expenses | $47.00M |
| Operating Income/Loss | -$48.00M |
| Income/Loss From Continuing Operations After Tax | -$53.29M |
| Income/Loss From Continuing Operations Before Tax | -$53.29M |
| Interest Expense, Operating | $23.00K |
| Net Income/Loss | -$53.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$53.29M |
| Net Income/Loss Available To Common Stockholders, Basic | -$65.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $12.56M |
| Preferred Stock Dividends And Other Adjustments | $12.56M |
| Basic Earnings Per Share | -$0.77 |
| Diluted Earnings Per Share | -$0.77 |
| Basic Average Shares | 94,771,219 |
| Diluted Average Shares | 94,771,219 |
| Assets | $53.20M |
| Current Assets | $49.84M |
| Inventory | $486.00K |
| Other Current Assets | $49.36M |
| Noncurrent Assets | $3.36M |
| Fixed Assets | $862.00K |
| Intangible Assets | $421.00K |
| Other Non-current Assets | $2.07M |
| Liabilities | $27.36M |
| Current Liabilities | $26.21M |
| Accounts Payable | $751.00K |
| Other Current Liabilities | $25.46M |
| Noncurrent Liabilities | $1.16M |
| Equity | $25.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $25.84M |
| Liabilities And Equity | $53.20M |
| Net Cash Flow From Operating Activities | -$43.78M |
| Net Cash Flow From Operating Activities, Continuing | -$43.78M |
| Net Cash Flow From Investing Activities | -$405.00K |
| Net Cash Flow From Investing Activities, Continuing | -$405.00K |
| Net Cash Flow From Financing Activities | $77.03M |
| Net Cash Flow From Financing Activities, Continuing | $77.03M |
| Net Cash Flow | $32.84M |
| Net Cash Flow, Continuing | $32.84M |
| Comprehensive Income/Loss | -$53.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$53.29M |
| Other Comprehensive Income/Loss | $0.00 |